Please Wait.....
Report
Europe Nasal Spray Market - Industry Trends and Forecast to 2030
Market Report I 2023-03-01 I 182 Pages I Data Bridge Market Research
The Europe nasal spray market is projected to register a CAGR of 6.5% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.
Market Segmentation
Europe Nasal Spray Market, By Product Type (Decongestion Nasal Spray, Steroid Nasal Spray, Salt Water Solution/Saline Nasal Spray, and Others), Container Design (Pump Bottles and Pressurized Canisters), Dosage Form (Multi Dose, Unit/Single Dose, and Bi Dose), Therapeutic Class (Antihistamine, Nasal Steroid, Mast Cell Inhibitor, and Anticholinergic), Application (Nasal Congestion, Allergic and Non-Allergic Rhinitis, Central Nervous System Disorders, Vaccination, and Others), Prescription/Availability (Over The Counter and Prescribed), End User (Home Care Settings, Hospitals, Clinics, and Community Health Care), Country (Germany, U.K., France, Italy, Spain, Switzerland, Netherlands, Belgium, Russia, Turkey, and Rest of Europe) Industry Trends and Forecast to 2030
Some of the major factors contributing to the growth of the Europe nasal spray market are:
- Rise in the therapeutic application of the nasal spray
- Increase in the demand for nasal sprays for allergic diseases and pandemics such as COVID-19
Market Players
Some of the major market players operating in the Europe nasal spray market are:
- EMERGENT
- Cipla Inc.
- Sandoz International GmbH (A Part of Novartis)
- Aytu Health (A subsidiary of Aytu BioPharma, Inc.)
- Bayer AG
- GlaxoSmithKline plc.
- Assertio Therapeutics, Inc.
- Aurena Laboratories.
- J Pharmaceuticals
- St. Renatus.
- Ultratech India Limited
- Catalent, Inc.
- Teva Pharmaceuticals USA, Inc. (A subsidiary of Teva Pharmaceutical Industries Ltd)
- Pfizer Inc.
- Viatris Inc.
- LEEFORD HEALTHCARE LTD
- Aishwarya Group
TABLE OF CONTENTS
1 INTRODUCTION 23
1.1 OBJECTIVES OF THE STUDY 23
1.2 MARKET DEFINITION 23
1.3 OVERVIEW 23
1.4 LIMITATIONS 25
1.5 MARKETS COVERED 25
2 MARKET SEGMENTATION 27
2.1 MARKETS COVERED 27
2.2 GEOGRAPHICAL SCOPE 28
2.3 YEARS CONSIDERED FOR THE STUDY 29
2.4 CURRENCY AND PRICING 29
2.5 DBMR TRIPOD DATA VALIDATION MODEL 30
2.6 MULTIVARIATE MODELLING 33
2.7 PRODUCT TYPE LIFELINE CURVE 33
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 34
2.9 DBMR MARKET POSITION GRID 35
2.10 MARKET END USER COVERAGE GRID 36
2.11 VENDOR SHARE ANALYSIS 37
2.12 SECONDARY SOURCES 38
2.13 ASSUMPTIONS 38
3 EXECUTIVE SUMMARY 39
4 PREMIUM INSIGHTS 42
4.1 PORTER'S FIVE FORCES MODEL 45
4.2 PESTEL ANALYSIS 46
5 INDUSTRY INSIGHTS: EUROPE NASAL SPRAY MARKET 47
5.1 INDUSTRY INSIGHTS 47
6 REGULATIONS: EUROPE NASAL SPRAY MARKET 48
6.1 REGULATORY SCENARIO IN EUROPE 48
7 MARKET OVERVIEW 49
7.1 DRIVERS 51
7.1.1 INCREASE IN INFECTION AND ALLERGIC CASES 51
7.1.2 RISING PREVALENCE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND ASTHMA 51
7.1.3 EFFECTIVENESS OVER OTHER FORMS OF DRUG DELIVERY 52
7.1.4 IMPROVING PATIENT COMPLIANCE AND ACCEPTABILITY 53
7.2 RESTRAINTS 54
7.2.1 PRODUCT RECALLS 54
7.2.2 ADVERSE EFFECTS OF USING NASAL SPRAYS 55
7.3 OPPORTUNITIES 56
7.3.1 NEW RISING DEMAND FOR SELF-ADMINISTRATIVE DRUG DELIVERY 56
7.3.2 EXPANDING THERAPEUTIC APPLICATIONS FOR NASAL SPRAYS 56
7.3.3 STRATEGIC INITIATIVES TAKEN BY KEY MARKET PLAYERS 57
7.4 CHALLENGES 57
7.4.1 REGULATORY HURDLES 57
7.4.2 ADDICTION TO NASAL SPRAY 58
8 EUROPE NASAL SPRAY MARKET, BY PRODUCT TYPE 59
8.1 OVERVIEW 60
8.2 DECONGESTION NASAL SPRAY 63
8.3 STEROID NASAL SPRAY 64
8.4 SALT WATER SOLUTION/SALINE NASAL SPRAY 65
8.5 OTHERS 66
9 EUROPE NASAL SPRAY MARKET, BY CONTAINER DESIGN 67
9.1 OVERVIEW 68
9.2 PUMP BOTTLES 71
9.3 PRESSURIZED CANISTERS 72
10 EUROPE NASAL SPRAY MARKET, BY DOSAGE FORM 73
10.1 OVERVIEW 74
10.2 MULTI DOSE 77
10.3 UNIT/SINGLE DOSE 78
10.4 BI DOSE 79
11 EUROPE NASAL SPRAY MARKET, BY THERAPEUTIC CLASS 81
11.1 OVERVIEW 82
11.2 ANTIHISTAMINE 85
11.3 NASAL STEROIDS 86
11.4 MAST CELL INHIBITOR 87
11.5 ANTICHOLINERGIC 88
12 EUROPE NASAL SPRAY MARKET, BY APPLICATION 89
12.1 OVERVIEW 90
12.2 NASAL CONGESTION 93
12.3 ALLERGIC AND NON-ALLERGIC RHINITIS 94
12.4 CENTRAL NERVOUS SYSTEM DISORDERS 95
12.5 VACCINATION 96
12.6 OTHERS 97
13 EUROPE NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY 98
13.1 OVERVIEW 99
13.2 PRESCRIBED 102
13.3 OVER THE COUNTER 103
14 EUROPE NASAL SPRAY MARKET, BY END USER 105
14.1 OVERVIEW 106
14.2 HOME CARE SETTINGS 109
14.3 HOSPITALS 110
14.4 CLINICS 111
14.5 COMMUNITY HEALTH CARE 112
15 EUROPE NASAL SPRAY MARKET, BY REGION 113
15.1 EUROPE 114
15.1.1 GERMANY 122
15.1.2 U.K. 124
15.1.3 FRANCE 126
15.1.4 ITALY 128
15.1.5 SPAIN 130
15.1.6 SWITZERLAND 132
15.1.7 NETHERLANDS 134
15.1.8 BELGIUM 136
15.1.9 RUSSIA 138
15.1.10 TURKEY 140
15.1.11 REST OF EUROPE 142
16 EUROPE NASAL SPRAY MARKET, COMPANY LANDSCAPE 143
16.1 COMPANY SHARE ANALYSIS: EUROPE 143
17 SWOT ANALYSIS 144
18 COMPANY PROFILE 145
18.1 GLAXOSMITHKLINE PLC. 145
18.1.1 COMPANY SNAPSHOT 145
18.1.2 REVENUE ANALYSIS 145
18.1.3 COMPANY SHARE ANALYSIS 146
18.1.4 PRODUCT PORTFOLIO 146
18.1.5 RECENT DEVELOPMENTS 146
18.2 PFIZER INC. 148
18.2.1 COMPANY SNAPSHOT 148
18.2.2 REVENUE ANALYSIS 148
18.2.3 COMPANY SHARE ANALYSIS 149
18.2.4 PRODUCT PORTFOLIO 149
18.2.5 RECENT DEVELOPMENTS 149
18.3 EMERGENT 151
18.3.1 COMPANY SNAPSHOT 151
18.3.2 REVENUE ANALYSIS 151
18.3.3 COMPANY SHARE ANALYSIS 152
18.3.4 PRODUCT PORTFOLIO 152
18.3.5 RECENT DEVELOPMENT 152
18.4 SANDOZ INTERNATIONAL GMBH (A PART OF NOVARTIS) 153
18.4.1 COMPANY SNAPSHOT 153
18.4.2 REVENUE ANALYSIS 153
18.4.3 COMPANY SHARE ANALYSIS 154
18.4.4 PRODUCT PORTFOLIO 154
18.4.5 RECENT DEVELOPMENT 154
18.5 CATALENT, INC. 155
18.5.1 COMPANY SNAPSHOT 155
18.5.2 REVENUE ANALYSIS 155
18.5.3 COMPANY SHARE ANALYSIS 156
18.5.4 PRODUCT PORTFOLIO 156
18.5.5 RECENT DEVELOPMENTS 156
18.6 AYTU HEALTH (A SUBSIDIARY OF AYTU BIOPHARMA, INC.) 158
18.6.1 COMPANY SNAPSHOT 158
18.6.2 REVENUE ANALYSIS 158
18.6.3 PRODUCT PORTFOLIO 159
18.6.4 RECENT DEVELOPMENTS 159
18.7 AISHWARYA GROUP 160
18.7.1 COMPANY SNAPSHOT 160
18.7.2 PRODUCT PORTFOLIO 160
18.7.3 RECENT DEVELOPMENTS 160
18.8 ASSERTIO THERAPEUTICS, INC. 161
18.8.1 COMPANY SNAPSHOT 161
18.8.2 REVENUE ANALYSIS 161
18.8.3 PRODUCT PORTFOLIO 162
18.8.4 RECENT DEVELOPMENT 162
18.9 AURENA LABORATORIES. 163
18.9.1 COMPANY SNAPSHOT 163
18.9.2 PRODUCT PORTFOLIO 163
18.9.3 RECENT DEVELOPMENTS 163
18.10 BAYER AG 165
18.10.1 COMPANY SNAPSHOT 165
18.10.2 REVENUE ANALYSIS 165
18.10.3 COMPANY SHARE ANALYSIS 166
18.10.4 PRODUCT PORTFOLIO 166
18.10.5 RECENT DEVELOPMENTS 166
18.11 CIPLA INC. 168
18.11.1 COMPANY SNAPSHOT 168
18.11.2 REVENUE ANALYSIS 168
18.11.3 PRODUCT PORTFOLIO 169
18.11.4 RECENT DEVELOPMENT 169
18.12 J PHARMACEUTICALS. 170
18.12.1 COMPANY SNAPSHOT 170
18.12.2 PRODUCT PORTFOLIO 170
18.12.3 RECENT DEVELOPMENTS 170
18.13 LEEFORD HEALTHCARE LTD 171
18.13.1 COMPANY SNAPSHOT 171
18.13.2 PRODUCT PORTFOLIO 171
18.13.3 RECENT DEVELOPMENTS 171
18.14 ST. RENATUS. 172
18.14.1 COMPANY SNAPSHOT 172
18.14.2 PRODUCT PORTFOLIO 172
18.14.3 RECENT DEVELOPMENTS 172
18.15 TEVA PHARMACEUTICALS USA, INC. (A SUBSIDIARY OF TEVA PHARMACEUTICAL INDUSTRIES LTD) 173
18.15.1 COMPANY SNAPSHOT 173
18.15.2 REVENUE ANALYSIS 173
18.15.3 PRODUCT PORTFOLIO 174
18.15.4 RECENT DEVELOPMENTS 174
18.16 ULTRATECH INDIA LIMITED 175
18.16.1 COMPANY SNAPSHOT 175
18.16.2 PRODUCT PORTFOLIO 175
18.16.3 RECENT DEVELOPMENTS 175
18.17 VIATRIS INC. 176
18.17.1 COMPANY SNAPSHOT 176
18.17.2 REVENUE ANALYSIS 176
18.17.3 COMPANY SHARE ANALYSIS 177
18.17.4 PRODUCT PORTFOLIO 177
18.17.5 RECENT DEVELOPMENT 177
19 QUESTIONNAIRE 178
20 RELATED REPORTS 182
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security